0001533743 2026-10-09 2026-10-09 0001533743 1 2026-10-09 2026-10-09 shares iso4217:USD shares iso4217:USD pure S-3 S-3 Processa Pharmaceuticals, Inc. false Equity Common Stock, $0.0001 par value per share true 306574202 1.52 465992787.04 0.000087 40541.38 465992787.04 40541.38 0 0 40541.38 <table style="font-size: 12pt; border-spacing: 0px; border-collapse: collapse; width: 100%;"> <tr style="height: 0px; font-size: 0px;"><td style="width: 1%;"> </td><td style="width: 99%;"> </td></tr><tr style="vertical-align: top;"> <td style="padding: 0px 0pt;"> <div style="margin-bottom: 4pt;"> <span style="font-size: 10.0pt;">1</span> </div> </td> <td style="padding: 0px 5.4pt; text-align: left;"> <div style="margin-bottom: 4pt;"> <span style="font-size: 10.0pt;">Consists of an aggregate of up to 306,574,202 shares of the Registrant’s common stock, par value $0.0001 per share (the "Common Stock”) issuable upon the conversion of an aggregate of 306,574.202 shares of the Registrant’s Series A Non-Voting Convertible Preferred Stock, par value $0.0001 per share. Pursuant to Rule 416 under the Securities Act of 1933, as amended, the shares of Common Stock being registered hereunder include such indeterminate number of shares of Common Stock as may be issuable with respect to the shares of Common Stock being registered hereunder as a result of stock splits, stock dividends or similar transactions. Pursuant to Rule 457(c) under the Securities Act, calculated on the basis of the average of the high and low prices per share of Common Stock reported on The Nasdaq Stock Market on October 06, 2026.</span> </div> </td> </tr> </table> N/A N/A 0001533743 EX-FILING FEES